Revelation Biosciences- Warrants(10/01/2027) OverviewRevelation Biosciences- Warrants(10/01/2027) EBIT
EBIT (Earnings Before Interest and Taxes) analysis for REVBW.
Quarterly EBIT
-$3.09M
↓ 47.61% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$14.86B
↓ 181673.74% YoY
Trailing 12 months ending Mar 31, 2026